| Title: | Comprehensive assessment of PINK1 variants in Parkinson's disease |
| Journal: | Neurobiology of Aging |
| Published: | 10 Mar 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32249012/ |
| DOI: | https://doi.org/10.1016/j.neurobiolaging.2020.03.003 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236133 |
Publication 4588
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Multiple genes have been associated with monogenic Parkinson's disease and Parkinsonism syndromes. Mutations in PINK1 (PARK6) have been shown to result in autosomal recessive early-onset Parkinson's disease. In the past decade, several studies have suggested that carrying a single heterozygous PINK1 mutation is associated with increased risk for Parkinson's disease. Here, we comprehensively assess the role of PINK1 variants in Parkinson's disease susceptibility using several large data sets totalling 376,558 individuals including 13,708 cases with Parkinson's disease and 362,850 control subjects. After combining these data, we did not find evidence to support a role for heterozygous PINK1 mutations as a robust risk factor for Parkinson's disease.11 Authors
- Lynne Krohn
- Francis P. Grenn
- Mary B. Makarious
- Jonggeol Jeffrey Kim
- Sara Bandres-Ciga
- Dorien A. Roosen
- Ziv Gan-Or
- Mike A. Nalls
- Andrew B. Singleton
- Cornelis Blauwendraat
- International Parkinson's Disease Genomics Consortium
Enabling scientific discoveries that improve human health